Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
1601 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 8
1602 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 12
1603 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 8
1604 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 52
1605 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 57
1606 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 66
1607 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 5
1608 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 54
1609 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 56
1610 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 3
1611 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2024 Standard Therapy Poland 7
1612 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2024 Standard Therapy Poland 7
1613 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2024 Standard Therapy Poland 9
1614 Bone Marrow Allogeneic B-Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 7
1615 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2024 Standard Therapy Poland 4
1616 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2024 Standard Therapy Poland 41
1617 Bone Marrow Allogeneic Chronic Lymphocytic Leukemia Richter Transformation Hematology 2024 Standard Therapy Poland 55
1618 Bone Marrow Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 67
1619 Bone Marrow Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 12
1620 Bone Marrow Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2024 Standard Therapy Poland 61
1621 Bone Marrow Allogeneic Genetically Determined Thrombocytopenia Hematology 2024 Standard Therapy Poland 4
1622 Bone Marrow Allogeneic High Risk Acute Myeloid Leukaemia Hematology 2024 Standard Therapy Poland 13
1623 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 32
1624 Bone Marrow Allogeneic Inherited Metabolic Disease Hematology 2024 Standard Therapy Poland 11
1625 Bone Marrow Allogeneic Mds-Rcc Relapse Hematology 2024 Standard Therapy Poland 14
1626 Bone Marrow Allogeneic Mixed Cellularity Hodgkin Lymphoma Hematology 2024 Standard Therapy Poland 43
1627 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 14
1628 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 8
1629 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 14
1630 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 67
1631 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 9
1632 Bone Marrow Allogeneic Osteopetrosis type B Hematology 2024 Standard Therapy Poland 13
1633 Bone Marrow Allogeneic Other Leukemia Hematology 2024 Standard Therapy Poland 9
1634 Bone Marrow Allogeneic Primary Immunodeficiency Hematology 2024 Standard Therapy Poland 7
1635 Bone Marrow Allogeneic Primary Immunodeficiency Xlp-1 Hematology 2024 Standard Therapy Poland 18
1636 Bone Marrow Allogeneic Relapse T-Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 12
1637 Bone Marrow Allogeneic Secondary Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 4
1638 Bone Marrow Allogeneic Secondary Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 15
1639 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 7
1640 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 3
1641 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 10
1642 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 21
1643 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 18
1644 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 49
1645 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 16
1646 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 24
1647 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 13
1648 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 14
1649 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 21
1650 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 7
1651 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2024 Standard Therapy Poland 2
1652 Bone Marrow Allogeneic Severe Congenital Neutropenia Hematology 2024 Standard Therapy Poland 1
1653 Bone Marrow Allogeneic Shwachman-Diamond Syndrome Hematology 2024 Standard Therapy Poland 10
1654 Bone Marrow Allogeneic Sickle Cell Disease Hematology 2024 Standard Therapy Poland 9
1655 Bone Marrow Allogeneic Biphenotypic Acute Leukemia Hematology 2024 Standard Therapy Ukraine 10
1656 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 58
1657 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy United Kingdom 12
1658 Bone Marrow Allogeneic hemophagocytic lymphohistiocytosis Hematology 2024 Standard Therapy Sweden 4 months
1659 Bone Marrow Allogeneic Severe combined immunodeficiency Hematology 2024 Standard Therapy Germany 1
1660 Bone Marrow Allogeneic Beta-Thalassemia Major Hematology 2024 Standard Therapy India 11
1661 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Austria 4
1662 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Norway 33
1663 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Spain 16
1664 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Switzerland 5
1665 Bone Marrow Allogeneic T- Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Ireland 6
1666 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 12
1667 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2024 Standard Therapy USA 4 months
1668 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Belgium 50
1669 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy France 31
1670 Bone Marrow Allogeneic Chronic myelomonocytic leukemia Hematology 2024 Standard Therapy Italy 64
1671 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy France 10
1672 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 12
1673 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy USA 4
1674 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Canada 8
1675 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 17
1676 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy USA 8
1677 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy USA 67
1678 Bone Marrow Allogeneic Hodgkins Lymphoma Hematology 2024 Standard Therapy United Kingdom 36
1679 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 72
1680 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 9
1681 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2024 Standard Therapy USA 3
1682 Apheresis Allogeneic A- Thalassemia Hematology 2024 Standard Therapy Poland 11
1683 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 13
1684 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 21
1685 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 22
1686 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 38
1687 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 41
1688 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 44
1689 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 44
1690 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 48
1691 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 50
1692 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 50
1693 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 55
1694 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 59
1695 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 60
1696 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 63
1697 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 44
1698 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 59
1699 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 51
1700 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 34